Imatinib-impurities | Pharmaffiliates

imatinib

Imatinib is a small molecule kinase inhibitor used to treat certain types of cancer. It is occasionally referred to as CGP57148B or STI571. It is used in treating chronic myelogenous leukemia, gastrointestinal stromal tumors and a number of other malignancies. Reference standards of Imatinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Imatinib Mesylate (IPRS/118/12)-from IPC
    [catalogue_number] => PA IPIPRS 118 12
    [category_ids] => ,151,
    [chemical_name] => 
    [weight] => NA
    [form] => 
    [cas] => NA
    [pslug] => imatinib-mesylate-iprs-118-12-paipiprs11812
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)

Imatinib Mesylate (IPRS/118/12)-from IPC


  • Catalogue No.:PA IPIPRS 118 12

  • CAS :

    NA

  • Molecular Formula :

  • Molecular Weight : NA